Intrinsic Value of S&P & Nasdaq Contact Us

Humacyte, Inc. HUMA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.50
+511.3%

Humacyte, Inc. (HUMA) has 12 identified peers for comparison in the Healthcare sector. Peers include CRNX, CYTK, GPCR, HCWB, ICVX, IMCR and others.

HUMA has a market capitalization of $115.4M, compared to an average peer market cap of $2.08B. HUMA is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message